These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing. Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of disseminated pilocytic astrocytomas. Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390 [TBL] [Abstract][Full Text] [Related]
7. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. Jeuken JW; Wesseling P J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706 [TBL] [Abstract][Full Text] [Related]
8. A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma. Yde CW; Sehested A; Mateu-Regué À; Østrup O; Scheie D; Nysom K; Nielsen FC; Rossing M Cancer Genet; 2016 Oct; 209(10):440-444. PubMed ID: 27810072 [TBL] [Abstract][Full Text] [Related]
9. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic role and clinical relevance of determination of BRAF status in brain tumors. Gessi M; Pietsch T Per Med; 2013 Jun; 10(4):405-412. PubMed ID: 29783415 [TBL] [Abstract][Full Text] [Related]
11. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status. Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035 [TBL] [Abstract][Full Text] [Related]
12. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. Hasselblatt M; Riesmeier B; Lechtape B; Brentrup A; Stummer W; Albert FK; Sepehrnia A; Ebel H; Gerss J; Paulus W Neuropathol Appl Neurobiol; 2011 Dec; 37(7):803-6. PubMed ID: 21696415 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic targets in pilocytic astrocytoma based on genetic analysis. Reis GF; Tihan T Semin Pediatr Neurol; 2015 Mar; 22(1):23-7. PubMed ID: 25976257 [TBL] [Abstract][Full Text] [Related]
14. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations. Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883 [TBL] [Abstract][Full Text] [Related]
15. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior. Bannykh SI; Mirocha J; Nuno M; Lopategui J; Kandala G Clin Neuropathol; 2014; 33(6):388-98. PubMed ID: 25066317 [TBL] [Abstract][Full Text] [Related]